Aadi Bioscience, Inc.
US ˙ NasdaqCM ˙ US00032Q1040
QUESTO SIMBOLO NON E' PIU' ATTIVO

SecurityAADI / Aadi Bioscience, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership351,385 shares
Latest Disclosed Value $ 1,212,278
BlackRock, Inc. reports 17.52% increase in ownership of AADI / Aadi Bioscience, Inc.

On May 13, 2026 - BlackRock, Inc. filed a 13F-HR form disclosing ownership of 351,385 shares of Aadi Bioscience, Inc. (US:AADI) valued at $1,212,278 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 299,011 shares of Aadi Bioscience, Inc.. This represents a change in shares of 17.52% during the quarter. The current value of the position is $720,339 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F WHITEHAWK THERAPEUTICS COM 00032Q104 351,385 52,374 17.52 1,212 67.63 0.0000
2026-02-12 2025-12-31 13F WHITEHAWK THERAPEUTICS COM 00032Q104 299,011 2,853 0.96 724 28.65 0.0000
2025-11-12 2025-09-30 13F WHITEHAWK THERAPEUTICS COM 00032Q104 296,158 -2,162 -0.72 563 0.90 0.0000
2025-08-12 2025-06-30 13F WHITEHAWK THERAPEUTICS COM 00032Q104 298,320 57,071 23.66 558 29.84 0.0000
2025-05-02 2025-03-31 13F WHITEHAWK THERAPEUTICS COM 00032Q104 241,249 -2,641 -1.08 429 -44.21 0.0000
2025-02-07 2024-12-31 13F AADI BIOSCIENCE COM 00032Q104 243,890 1,002 0.41 769 53.80 0.0000
2024-11-13 2024-09-30 13F AADI BIOSCIENCE COM 00032Q104 242,888 -77,359 -24.16 500 7.07 0.0000
2024-08-13 2024-06-30 13F AADI BIOSCIENCE COM 00032Q104 320,247 -720,759 -69.24 468 -80.82 0.0000
2024-05-10 2024-03-31 13F AADI BIOSCIENCE COM 00032Q104 1,041,006 -40,625 -3.76 2,436 11.49 0.0001
2024-02-13 2023-12-31 13F AADI BIOSCIENCE COM 00032Q104 1,081,631 75,825 7.54 2,185 -55.14 0.0001
2023-11-13 2023-09-30 13F AADI BIOSCIENCE COM 00032Q104 1,005,806 -11,318 -1.11 4,868 -30.03 0.0001
2023-08-11 2023-06-30 13F AADI BIOSCIENCE COM 00032Q104 1,017,124 140,959 16.09 6,957 9.68 0.0002
2023-05-12 2023-03-31 13F AADI BIOSCIENCE COM 00032Q104 876,165 -15,698 -1.76 6,343 -44.56 0.0002
2023-02-13 2022-12-31 13F AADI BIOSCIENCE COM 00032Q104 891,863 33,361 3.89 11,443 -5.67 0.0004
2022-11-14 2022-09-30 13F AADI BIOSCIENCE COM 00032Q104 858,502 -44,175 -4.89 12,130 9.07 0.0004
2022-08-12 2022-06-30 13F AADI BIOSCIENCE COM 00032Q104 902,677 592,550 191.07 11,121 111.31 0.0004
2022-05-12 2022-03-31 13F AADI BIOSCIENCE COM 00032Q104 310,127 573 0.19 5,263 -29.59 0.0001
2022-02-10 2021-12-31 13F AADI BIOSCIENCE COM 00032Q104 309,554 293,304 1,804.95 7,475 1,463.81 0.0002
2021-11-09 2021-09-30 13F AADI BIOSCIENCES COM 00032Q104 16,250 16,250 478 0.0000
2021-08-11 2021-06-30 13F AERPIO PHARMACEUTICALS COM 00810B105 241,097 115,727 92.31 407 151.23 0.0000
2021-05-07 2021-03-31 13F AERPIO PHARMACEUTICALS COM 00810B105 125,370 6,976 5.89 162 39.66 0.0000
2021-02-05 2020-12-31 13F AERPIO PHARMACEUTICALS COM 00810B105 118,394 4,080 3.57 116 -32.16 0.0000
2020-11-06 2020-09-30 13F AERPIO PHARMACEUTICALS COM 00810B105 114,314 48 0.04 171 19.58 0.0000
2020-08-14 2020-06-30 13F AERPIO PHARMACEUTICALS COM 00810B105 114,266 -61,884 -35.13 143 47.42 0.0000
2020-05-01 2020-03-31 13F AERPIO PHARMACEUTICALS COM 00810B105 176,150 6,312 3.72 97 -8.49 0.0000
2020-02-13 2019-12-31 13F AERPIO PHARMACEUTICALS COM 00810B105 169,838 1,440 0.86 106 -7.02 0.0000
2019-11-08 2019-09-30 13F AERPIO PHARMACEUTICALS COM 00810B105 168,398 3,176 1.92 114 -24.00 0.0000
2019-08-22 2019-06-30 13F/A-1 AERPIO PHARMACEUTICALS COM 00810B105 165,222 72,796 78.76 150 80.72 0.0000
2019-08-13 2019-06-30 13F AERPIO PHARMACEUTICALS COM 00810B105 165,222 72,796 150
2019-05-09 2019-03-31 13F AERPIO PHARMACEUTICALS COM 00810B105 92,426 92,426 83 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.